Event Details

Acorda Therapeutics, Inc. Provides Update on Tozadenant Development Program

November 15, 2017 Time: 08:30 AM EST

Stock Quote

ACOR (Common Stock) $ 6.88 +0.32 (+4.88%) Volume: 956,636 MORE July 16, 2019

Email Alerts

Un-subscribe from email alerts
Email Address *
Mailing Lists *





 
Enter the code shown above.